Showing results (351-360 of 639) with videos related to
Sort By:
Pageof 64
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Promoter hypermethylation profile of ovarian epithelial neoplasmsPrakash B Makarla, M Hossein Saboorian, Raheela Ashfaq, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2007
Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or lessNaruyuki Kobayashi, Shinichi Toyooka, Junichi Soh, et al.The Annals of Thoracic Surgery|June 6, 2016
The Feasibility of Median Sternotomy With or Without Thoracotomy for Locally Advanced Non-Small Cell Lung Cancer Treated With Induction ChemoradiotherapyHiroki Sato, Shinichi Toyooka, Junichi Soh, et al.Cancer Science|February 3, 2007
Activation of downstream epidermal growth factor receptor (EGFR) signaling provides gefitinib-resistance in cells carrying EGFR mutationAkiko Uchida, Seiki Hirano, Hiroyuki Kitao, et al.Chest|May 12, 2009
CT fluoroscopy-guided biopsy of 1,000 pulmonary lesions performed with 20-gauge coaxial cutting needles: diagnostic yield and risk factors for diagnostic failureTakao Hiraki, Hidefumi Mimura, Hideo Gobara, et al.Heliyon|April 7, 2023
Diagnostic value of circulating microRNA-21 in chronic lung allograft dysfunction after bilateral cadaveric and living-donor lobar lung transplantationToshio Shiotani, Seiichiro Sugimoto, Yasuaki Tomioka, et al.Surgical Infections|December 30, 2025
Late Recurrence of Empyema More Than a Decade after Window Thoracostomy: Secondary Aspergillus Infection Superimposed on Prior MRSA Empyema, Successfully Managed by Stepwise Surgical and Endobronchial Definitive ClosureKaoru Kondo, Shin Tanaka, Haruchika Yamamoto, et al.Molecular Cancer Therapeutics|May 22, 2016
Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCCYu Nakamura, Yosuke Togashi, Hirokazu Nakahara, et al.Lung Cancer (Amsterdam, Netherlands)|July 6, 2026
ULK1, a novel therapeutic target to delay drug tolerance to EGFR-TKIs in an EGFR-mutant non-small cell lung cancer modelAyako Morita, Kammei Rai, Tadahiro Kuribayashi, et al.Breast Cancer Research : BCR|June 29, 2010
The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cellsHirokuni Ikeda, Naruto Taira, Fumikata Hara, et al.Pageof 64